Funding Rounds
Step Pharma Series B (2021, $41M)
Step PharmaManufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).
Summary
Stage: Series B
Raised Amount: $41.23M
Raised Date: 2021-01-01
Stage: Series B
Raised Amount: $41.23M
Raised Date: 2021-01-01
